Rapamycin Inhibition of the Akt/mTOR Pathway Blocks Select Stages of VEGF-A <sup>164</sup> –Driven Angiogenesis, in Part by Blocking S6Kinase

Qi Xue(Beth Israel Deaconess Medical Center), Laura E. Benjamin(Beth Israel Deaconess Medical Center)

Arteriosclerosis Thrombosis and Vascular Biology

May 15, 2009

10.1161/atvbaha.109.185918

Cited by 100

Related Papers

Endothelial Akt Signaling Is Rate-Limiting for Rapamycin Inhibition of Mouse Mammary Tumor Progression

|Cancer Research|2007|53

Supplemental Methods from Stromal-Based Signatures for the Classification of Gastric Cancer

|Unknown|2023|0